HomeClinical TopicsFDA approves mobile app to encourage retention in opioid use disorder recovery...

FDA approves mobile app to encourage retention in opioid use disorder recovery programs

Author(s):

On Dec. 10, the FDA approved reSET-O app, a prescription cognitive behavioral therapy designed to encourage those with opioid use disorder to stay in recovery programs.

Read more via U.S. Food & Drug Administration.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content